PfRAS

U.S. Army Medical Research and Development Command · Phase 1 active Biologic

At a glance

Generic name	PfRAS
Also known as	True-immunization, PfRAS infected Anopheles stephensi mosquitoes
Sponsor	U.S. Army Medical Research and Development Command
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Immunization Via Mosquito Bite With Radiation-attenuated Sporozoites (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

PfRAS CI brief — competitive landscape report
PfRAS updates RSS · CI watch RSS
U.S. Army Medical Research and Development Command portfolio CI